VIRAMAL LIMITED
Research and experimental development on biotechnology
VIRAMAL LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
167-169 Great Portland Street 5th Floor London W1W 5PF England
Full company profile for VIRAMAL LIMITED (08485006), an active life sciences and medical technology company based in London, England. Incorporated 12 Apr 2013. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2014–2024)
Cash in Bank
£85.04k
Net Assets
£1.36M
Total Liabilities
£773.26k
Turnover
N/A
Employees
11
Debt Ratio
36%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
See all 4 funding rounds
Sign up to view complete fundraising history
Investors (4)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 2 | Apr 2016 | Series A, Seed |
| Investor 1 | Mar 2018 | Series A |
| Investor 3 | Mar 2018 | Series A |
See all 4 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Fiore, Simona, Dr | Director | Italian | England | 27 Mar 2020 | Active |
| Niederstaetter, Anne Katrin | Director | British | England | 21 Mar 2022 | Active |
| Singh Sachdeva, Gurpartap | Director | American | United States | 1 Jul 2019 | Active |
See all 15 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
No PSC information available
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 31 Mar 2026 | Confirmation Statement | Confirmation statement made on 2 Mar 2026 with updates | |
| 30 Mar 2026 | Capital | Allotment of shares (GBP 567,974.58) on 27 Oct 2025 | |
| 30 Mar 2026 | Capital | Allotment of shares (GBP 568,391.24) on 27 Oct 2025 | |
| 30 Mar 2026 | Capital | Allotment of shares (GBP 568,391.24) on 21 Feb 2025 | |
| 30 Mar 2026 | Capital | Allotment of shares (GBP 568,557.9) on 27 Oct 2025 |
Confirmation statement made on 2 Mar 2026 with updates
Allotment of shares (GBP 567,974.58) on 27 Oct 2025
Allotment of shares (GBP 568,391.24) on 27 Oct 2025
Allotment of shares (GBP 568,391.24) on 21 Feb 2025
Allotment of shares (GBP 568,557.9) on 27 Oct 2025
Recent Activity
Latest Activity
Confirmation statement made on 2 Mar 2026 with updates
1 months ago on 31 Mar 2026
Allotment of shares (GBP 567,974.58) on 27 Oct 2025
1 months ago on 30 Mar 2026
Allotment of shares (GBP 568,391.24) on 27 Oct 2025
1 months ago on 30 Mar 2026
Allotment of shares (GBP 568,391.24) on 21 Feb 2025
1 months ago on 30 Mar 2026
Allotment of shares (GBP 568,557.9) on 27 Oct 2025
1 months ago on 30 Mar 2026